NCT02266680

Brief Summary

The goal of this study is to determine the safety and effectiveness of Breathing Focused Yoga (BFY) in improving symptoms of social anxiety disorder (SAD). Patients with SAD will be randomized to 8 weeks of yoga or 8 weeks of wait-list. Symptom severity and quality of life will be compared between the two groups before and after the 8 weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

October 7, 2014

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 17, 2014

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2017

Completed
Last Updated

July 19, 2017

Status Verified

September 1, 2016

Enrollment Period

5 years

First QC Date

October 7, 2014

Last Update Submit

July 18, 2017

Conditions

Keywords

Social AnxietyYoga

Outcome Measures

Primary Outcomes (1)

  • Change in Liebowitz Social Anxiety Scale (LSAS) Total Score

    Baseline to study endpoint (Week 8)

Secondary Outcomes (4)

  • Change in Clinical Global Impression Scale

    Baseline to study endpoint (Week 8)

  • Change in Hamilton Depression Rating Scale (HAM-D) Total Score

    Baseline to study endpoint (Week 8)

  • Change in Quality of Life Enjoyment and Satisfaction Scale (QLESQ) Total Score

    Baseline to study endpoint (Week 8)

  • Change in Quick Inventory of Depressive Symptomatology (QIDS) Total Score

    Baseline to study endpoint (Week 8)

Study Arms (2)

Yoga Treatment Group

EXPERIMENTAL

BFY will be taught by a trained yoga instructor. Group sessions will be offered twice a week for 60 minutes each (i.e., a total of 2 hours per week), for 8 weeks.

Behavioral: Yoga Treatment Group

Waitlist Group

NO INTERVENTION

Waitlisted participants will receive BFY at the next available group after their waitlist period is completed

Interventions

The breathing focused yoga intervention is a manualized yoga protocol developed at CAMH by the Mood and Anxiety Disorders group, with yoga teacher, Ms. Tiffany Garfinkel, as the lead. BFY incorporates postures and meditation, but there is a special focus on controlled breathing at different rates, including Ujjaji or slow inhalation, exhalation and holding of breath; Bhastrika or Kapalabhati, two types of vigorous breathing with forced exhalation; and cyclical breathing or a repeated pattern of slow, moderate and fast breathing.

Also known as: Breathing Focused Yoga
Yoga Treatment Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female patients aged 18-65 years
  • Primary diagnosis of SAD, per the DSM-IV-TR (APA, 2000)
  • LSAS score of ≥50
  • Absence of serious medical illness
  • Not on any psychotropic medications currently, or on stable medications for at least 8 weeks prior to starting treatment
  • Short-acting benzodiazepines (e.g. lorazepam 1 mg prn) and sleep medications (e.g. zopiclone 7.5 mg prn) may be used, but not within 12 hours prior to a study visit

You may not qualify if:

  • Current primary diagnosis of major depressive episode, mania or psychosis
  • A score of ≥15 on the first 17 items of the HAM-D at Screening or Baseline
  • Diagnosis of a substance abuse disorder within the prior 6 months
  • Presence of medical or mental health conditions that would inhibit the patient's ability to participate in the study
  • Currently receiving any structured formal psychotherapy (supportive therapy is allowed)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre for Addition and Mental Health

Toronto, Ontario, M6J 1H4, Canada

Location

Related Links

MeSH Terms

Conditions

Phobia, Social

Condition Hierarchy (Ancestors)

Phobic DisordersAnxiety DisordersMental Disorders

Study Officials

  • Arun Ravindran, MD, PhD

    Centre for Addiction and Mental Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 7, 2014

First Posted

October 17, 2014

Study Start

January 1, 2012

Primary Completion

January 1, 2017

Study Completion

January 30, 2017

Last Updated

July 19, 2017

Record last verified: 2016-09

Locations